Department of Pathology and Immunology, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
Center for Genomic Integrity, Institute for Basic Science, Ulsan, Republic of Korea.
Crit Rev Biochem Mol Biol. 2021 Apr;56(2):125-136. doi: 10.1080/10409238.2020.1869173. Epub 2021 Jan 12.
DNA damaging agents have been a cornerstone of cancer therapy for nearly a century. The discovery of many of these chemicals, particularly the alkylating agents, are deeply entwined with the development of poisonous materials originally intended for use in warfare. Over the last decades, their anti-proliferative effects have focused on the specific mechanisms by which they damage DNA, and the factors involved in the repair of such damage. Due to the variety of aberrant adducts created even for the simplest alkylating agents, numerous pathways of repair are engaged as a defense against this damage. More recent work has underscored the role of RNA damage in the cellular response to these agents, although the understanding of their role in relation to established DNA repair pathways is still in its infancy. In this review, we discuss the chemistry of alkylating agents, the numerous ways in which they damage nucleic acids, as well as the specific DNA and RNA repair pathways which are engaged to counter their effects.
DNA 损伤剂作为癌症治疗的基石已有近一个世纪的历史。这些化学物质中的许多发现,特别是烷化剂,与最初用于战争的有毒物质的发展密切相关。在过去的几十年中,它们的抗增殖作用主要集中在它们破坏 DNA 的特定机制以及涉及修复这种损伤的因素上。由于即使是最简单的烷化剂也会产生多种异常加合物,因此会涉及许多修复途径来抵御这种损伤。最近的研究强调了 RNA 损伤在细胞对这些试剂的反应中的作用,尽管它们在与已建立的 DNA 修复途径的关系中的作用仍处于起步阶段。在这篇综述中,我们讨论了烷化剂的化学性质、它们破坏核酸的多种方式,以及为了抵消其作用而涉及的特定 DNA 和 RNA 修复途径。